UnknownNot applicableNCT01586767
Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
Studying Esthesioneuroblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Annie W Chan, MD, MDMassachusetts General Hospital
- Intervention
- Proton radiation therapy(radiation)
- Enrollment
- 45 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2025
Study locations (2)
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Mayo Clinic Rochester, Rochester, Minnesota, United States
Collaborators
National Institutes of Health (NIH) · National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01586767 on ClinicalTrials.govOther trials for Esthesioneuroblastoma
Additional recruiting or active studies for the same condition.